Efficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection: a randomized, non-inferiority trial in the Russian Federation

Similar Items

• Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation
  od: Burova, Natalia, i dr.
  Izdano: (2018)
• Locally Delivered Flurbiprofen 8.75 mg for Treatment and Prevention of Sore Throat: A Narrative Review of Clinical Studies
  od: de Looze, Ferdinandus, i dr.
  Izdano: (2019)
• Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography Method
  od: Turner, Rob, i dr.
  Izdano: (2021)
• Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial
  od: McNally, D., i dr.
  Izdano: (2009)
• Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study
  od: Donath, Frank, i dr.
  Izdano: (2018)